Heparan Sulfate, Chondroitin Sulfate, and Keratan Sulfate as Regulators of Tumor Malignancy
International Journal of Molecular Sciences · 17.10.2026 · 27 (20) · 9229
DOI: 10.3390/ijms27209229 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.10.2026. Verfasst von Yuki Ohkawa und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Glyco-Oncology and Medical Biochemistry, Next-Generation Precision Cancer Research Center, Frontier Exploratory Research Domain, Osaka …. Hauptthemen laut MEDLINE: Heparan Sulfate, Chondroitin Sulfates, Neoplasms, Keratan Sulfate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Osaka Prefecture, Mizutani Foundation for Glycoscience.
Abstract (Originalsprache)
All mammalian cells, which include cancer cells, express sugar chains on their cell surfaces. These sugar chains bind with proteins, lipids, and RNAs. These chains consist of as few as two or three monosaccharides in the shortest chains, and as many as several hundred to a thousand monosaccharides in the longest chains. The chains appear to have a multilayered structure, which makes cells appear to be covered in a coating of sugar. The expression patterns and levels of these sugar chains, also known as the glycocalyx, vary greatly depending on the cell or tissue, and are therefore thought to perform unique localized biological functions. Furthermore, changes in the glycocalyx changes in conjunction with the onset of disease are believed to be closely related to the development of pathological conditions. In this study, we focus on glycosaminoglycans such as heparan sulfate, chondroitin sulfate, and keratan sulfate—relatively long chains of glycans that constitute the glycocalyx—and introduce their biological functions and potential applications in cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Glyco-Oncology and Medical Biochemistry, Next-Generation Precision Cancer Research Center, Frontier Exploratory Research Domain, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku 541-8567, Osaka…
- Department of Molecular Oncology, Affiliated Graduate School of Medicine, The University of Osaka, 2-2 Yamadaoka, Suita 565-0871, Osaka, Japan.
ORCID-Profile: Yuki Ohkawa
Förderung
- Osaka Prefecture
- Mizutani Foundation for Glycoscience
Zitieren
APA
Ohkawa, Y., & Taniguchi, N. (2026). Heparan Sulfate, Chondroitin Sulfate, and Keratan Sulfate as Regulators of Tumor Malignancy. International Journal of Molecular Sciences, 27(20), 9229. https://doi.org/10.3390/ijms27209229
Vancouver
Ohkawa Y, Taniguchi N. Heparan Sulfate, Chondroitin Sulfate, and Keratan Sulfate as Regulators of Tumor Malignancy. International Journal of Molecular Sciences. 2026;27(20):9229. doi:10.3390/ijms27209229
BibTeX
@article{Ohkawa2026,
author = {Ohkawa, Yuki and Taniguchi, Naoyuki},
title = {Heparan Sulfate, Chondroitin Sulfate, and Keratan Sulfate as Regulators of Tumor Malignancy},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {20},
pages = {9229},
doi = {10.3390/ijms27209229}
}
EUVIMED